Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Elimination of Inter-Segment Revenue	-115.63M	-83.55M	-48.73M	-44.43M	-28.24M
ALL Others	304.17M	163.57M	160.24M	133.26M	81.73M
ALL Others Growth	85.95%	2.08%	20.24%	63.05%	161.36%
Cardiovascular Interventional Business	876.93M	771.93M	641.32M	497.05M	411.18M
Cardiovascular Interventional Business Growth	13.60%	20.36%	29.03%	20.89%	20.48%
Total	1.07B	851.95M	752.84M	585.88M	464.68M
Total Growth	25.06%	13.17%	28.50%	26.08%	29.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	809.00M	599.42M	549.50M	437.34M	361.76M
Mainland China Growth	34.97%	9.08%	25.65%	20.89%	46.75%
Europe	58.99M	50.68M	45.32M	46.92M	26.99M
Europe Growth	16.39%	11.84%	-3.42%	73.85%	-30.63%
The United States	46.06M	55.19M	46.64M	28.16M	18.88M
The United States Growth	-16.55%	18.33%	65.62%	49.14%	33.11%
Other countries and regions	151.43M	146.67M	111.38M	73.46M	57.04M
Other countries and regions Growth	3.25%	31.69%	51.62%	28.78%	-3.03%
Total	1.07B	851.95M	752.84M	585.88M	464.68M
Total Growth	25.06%	13.17%	28.50%	26.08%	29.64%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 9, 2026

Data Sources Report a data error